Sp176
MACHINE LEARNING APPLICATIONS FOR GI CANCER BIOMARKER DISCOVERY
Date
May 18, 2024
Explore related products in the following collection:
Presenter
Beckman Research Institute, City of Hope Comprehensive Cancer Center
Tracks
Related Products
Artificial Intelligence in GI Cancer Screening and Therapeutics
SOCIETY: AGA Join this session to review current and future applications for AI in assessing GI cancer risk, and guiding cancer screening and cancer therapeutics in research and clinical care settings…
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
TISSUE-BASED TRANSCRIPTOME SIGNATURE TO PREDICT RECURRENCE AFTER LOCAL RESECTION IN T1 COLORECTAL CANCER
Background: Tumor recurrence is the event that has a major impact on survival after local resection of submucosal colorectal cancers (T1 CRC). However, currently, there are no established biomarkers to predict disease-free survival (DFS) in T1 CRC…
CLOSTRIDIOIDES DIFFICILE INFECTION INDUCES A PRO-STEATOTIC AND PRO-INFLAMMATORY METABOLIC STATE IN LIVER
BACKGROUND: Recent studies suggest links between _Clostridioides difficile_ infection (CDI) and liver disorders, with non-alcoholic fatty liver disease (NAFLD) increasing CDI risk and CDI exacerbating the progression and prognosis of liver cirrhosis. Moreover, gut dysbiosis, often leading to _C…
